Diagnosis and management of group a streptococcal pharyngitis: a practice guideline

Clinical Infectious Diseases

Volumn 25, Issue 3, 1997, Pages 574-583

  Bisno, Alan L ^a   Gerber, Michael A ^a   Gwaltney Jr , Jack M ^a   Kaplan, Edward L ^a   Schwartz, Richard H ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN;

ADOLESCENT; ADULT; BACTERIAL INFECTION; CHILD; COST BENEFIT ANALYSIS; DIFFERENTIAL DIAGNOSIS; ECONOMICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MEDICAL SOCIETY; MICROBIOLOGY; PHARYNGITIS; PHARYNX; PRACTICE GUIDELINE; RECURRENT DISEASE; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; UNITED STATES; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL INFECTIONS; CHILD; COST-BENEFIT ANALYSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PHARYNGITIS; PHARYNX; RECURRENCE; SOCIETIES, MEDICAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; UNITED STATES; VIRUS DISEASES;

EID: 0031225659     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/513768     Document Type: Article

References (58)

1. Peter G. Streptococcal pharyngitis: current therapy and criteria for evaluation of new agents. Clin Infect Dis 1992; 14(suppl 2):S218-23.
2. Gross PA, Barren TL, Dellinger EP, et al. Purpose of quality standards for infectious diseases. Clin Infect Dis 1994; 18:421.
3. Bisno AL. Acute pharyngitis: etiology and diagnosis. Pediatrics 1996; 97(6pt2)(suppl):949-54.
4. Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child 1972; 124:352-8.
5. Cimolai N, Elford RW, Bryan L, Anand C, Berger P. Do the -hemolytic non-group A streptococci cause pharyngitis? Rev Infect Dis 1988; 10: 587-601.
6. Turner JC, Hayden GF, Kiselica D, Lohr J, Fishburne CF, Murren D. Association of group C /3-hemolytic streptococci with endemic pharyngitis among college students. JAMA 1990; 264:2644-7.
7. Meier FA, Centor RM, Graham L Jr, Dalton HP. Clinical and microbiological evidence for endemic pharyngitis among adults due to group C streptococci. Arch Intern Med 1990; 150:825-9.
8. Gerber MA, Randolph MF, Martin NJ, et al. Community-wide outbreak of group G Streptococcal pharyngitis. Pediatrics 1991; 87:598-603.
9. Wannamaker LW. Diagnosis of pharyngitis: clinical and epidemiologic features. In: Shulman ST, ed. Pharyngitis: management in an era of declining rheumatic fever. New York: Praeger, 1984:33-46.
10. Breese BB. A simple scorecard for the tentative diagnosis of Streptococcal pharyngitis. Am J Dis Child 1977; 131:514-7.
11. Stillerman M, Bernstein SH. Streptococcal pharyngitis: evaluation of clinical syndromes in diagnosis. Am J Dis Child 1961; 101:476-89.
12. Breese BB, Disney FA. The accuracy of diagnosis of beta-streptococcal infections on clinical grounds. J Pediatr 1954;44:670-3.
13. Gerber MA. Comparison of throat cultures and rapid strep tests for diagnosis of Streptococcal pharyngitis. Pediatr Infect Dis J 1989; 8:820-4.
14. Brien JH, Bass JW. Streptococcal pharyngitis: optimal site for throat culture. J Pediatr 1985; 106:781-3.
15. Gunn BA, Mesrobian R, Keiser JF, Bass J. Cultures of Streptococcus pyogenes from the oropharynx. Laboratory Medicine 1985; 16:369-71.
16. Schwartz RH, Gerber MA, McCoy P. Effect of atmosphere of incubation on the isolation of group A streptococci from throat cultures. J Lab Clin Med 1985; 106:88-92.
17. Lauer BA, Relier LB, Mirrett S. Effect of atmosphere and duration of incubation on primary isolation of group A streptococci from throat cultures. J Clin Microbiol 1983; 17:338-40.
18. Roddey OF Jr, Clegg HW, Martin ES, Swetenburg RL, Koonce EW. Comparison of throat culture methods for the recovery of group A streptococci in a pédiatrie office setting. JAMA 1995;274:1863-5.
19. Gerber MA. Diagnosis of pharyngitis: methodology of throat cultures. In: Shulman ST, ed. Pharyngitis: management in an era of declining rheumatic fever. New York: Praeger, 1984:61-72.
20. Kellogg JA. Suitability of throat culture procedures for detection of group A streptococci and as reference standards for evaluation of Streptococcal antigen detection kits. J Clin Microbiol 1990;28:165-9.
21. Ederer GM, Herrmann MM, Bruce R, Matsen JM, Chapman SS. Rapid extraction method with pronase B for grouping beta-hemolytic streptococci. Appl Microbiol 1972;23:285-8.
22. Murray PR, Wold AD, Hall MM, Washington JA II. Bacitracin differentiation of presumptive identification of group A /J-hemolytic streptococci: comparison of primary and purified plate testing. J Pediatr 1976; 89: 576-9.
23. Randolph MF, Gerber MA, DeMeo KK, Wright L. Effect of antibiotic therapy on the clinical course of Streptococcal pharyngitis. J Pediatr 1985; 106:870-5.
24. Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis: placebocontrolled double-blind evaluation of clinical response to penicillin therapy. JAMA 1985;253:1271-4.
25. Nelson JD, The effect of penicillin therapy on the symptoms and signs of Streptococcal pharyngitis. Pediatr Infect Dis J 1984;3:10-3.
26. Lieu TA, Fleisher GR, Schwartz JS. Clinical evaluation of a latex agglutination test for Streptococcal pharyngitis: performance and impact on treatment rates. Pediatr Infect Dis J 1988;7:847-54.
27. Gerber MA, Randolph MF, Chanatry J, Wright LL, DeMeo KK, Anderson LR. Antigen detection test for Streptococcal pharyngitis: evaluation of sensitivity with respect to true infections. J Pediatr 1986; 108:654-8.
28. Schlager TA, Hayden GA, Woods WA, Dudley SM, Hendley JO. Optical immunoassay for rapid detection of group A /J-hemolytic streptococci: should culture be replaced? Arch Pediafr Adolesc Med 1996; 150:245-8.
29. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981;98:326-35.
30. Gerber MA. Treatment failures and carriers: perception or problems? Pediatr Infect Dis J 1994; 13:576-9.
31. Committee on Infectious Diseases of the American Academy of Pediatrics. 1997 Red book: report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, Illinois: American Academy of Pediatrics, 1997: 483-94.
32. Brink WR, Rammelkamp CH Jr, Denny FW, Wannamaker LW. Effect of penicillin and aureomycin on the natural course of Streptococcal tonsillitis and pharyngitis. Am J Med 1951; 10:300-8.
33. Catanzaro FJ, Stetson CA, Morris AJ, et al. The role of the streptococcus in the pathogenesis of rheumatic fever. Am J Med 1954; 17:749-56.
34. Denny FW, Wannamaker LW, Brink WR, Rammelkamp CH Jr, Custer EA. Prevention of rheumatic fever. Treatment of the preceding streptococcic infection. JAMA 1950; 143:151-3.
35. Wannamaker LW, Rammelkamp CH Jr, Denny FW, et al. Prophylaxis of acute rheumatic fever by treatment of the preceding Streptococcal infection with various amounts of depot penicillin. Am J Med 1951; 10:673-95.
36. Siegel AC, Johnson EE, Stollerman GH. Controlled studies of Streptococcal pharyngitis in a pédiatrie population. I. Factors related to the attack rate of rheumatic fever. N Engl J Med 1961;265:559-66.
37. Chamovitz R, Catanzaro FJ, Stetson CA, Rammelkamp CH Jr. Prevention of rheumatic fever by treatment of previous Streptococcal infections. I. Evaluation of benzathine penicillin G. N Engl J Med 1954; 251: 466-71.
38. Frank PF, Stollerman GH, Miller LF. Protection of a military population from rheumatic fever: routine administration of benzathine penicillin G to healthy individuals. JAMA 1965; 193:775-83.
39. Wood HF, Feinstein AR, Taranta A, Epstein JA, Simpson R. Rheumatic fever in children and adolescents. A long-term epidemiologic study of subsequent prophylaxis, Streptococcal infections, and clinical sequelae. III. Comparative effectiveness of three prophylaxis regimens in preventing Streptococcal infections and rheumatic recurrences. Ann Intern Med 1964;60(suppl 5):31-46.
40. Coonan KM, Kaplan EL. In vitro susceptibility of recent North American group A Streptococcal isolates to eleven oral antibiotics. Pediatr Infect Dis J 1994; 13:630-5.
41. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute Streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995; 96:758-64.
42. World Health Organization. Rheumatic fever and rheumatic heart disease. WHO Technical Report Series no. 764. Geneva: World Health Organization, 1988.
43. Hamill J. Multicentre evaluation of azithromycin and penicillin V in the treatment of acute Streptococcal pharyngitis and tonsillitis in children. J Antimicrob Chemother 1993;31(suppl E):89-94.
44. Weippl G. Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci. J Antimicrob Chemother 1993;31(suppl E):95-101.
45. Hooton TM. A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. Am J Med 1991;91(suppl 3A): 23S-65.
46. Aujard Y, Boucot I, Brahimi N, Chiche D, Bingen E. Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children. Pediatr Infect Dis J 1995; 14:295-300.
47. Adam D. Hostalek U. Tröster K. 5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group. Infection 1995;23(suppl 2): S83-6.
48. Pichichero ME, Gooch WM, Rodriguez W, et al. Effective shortcourse treatment of acute group A /9-hemolytic streptococcal tonsillopharyngitis: ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children. Arch Pediatr Adolesc Med 1994; 148:1053-60.
49. Schwartz B, Elliott JA, Butler JC, et al. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis 1992:15:277-84.
50. DiPersio JR, File TM Jr., Stevens DL, Gardner WG, Petropoulos G, Dinsa K. Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers. Clin Infect Dis 1996;22:490 5.
51. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335:547-54.
52. Schwartz RH, Wientzen RL Jr, Pedreira F, Feroli EJ. Mella GW, Guandolo VL. Penicillin V for group A streptococcal pharyngotonsillitis: a randomized trial of seven vs ten days1 therapy. JAMA 1981;246:1790-5.
53. Kaplan EL. The group A streptococcal upper respiratory tract carrier state: an enigma. J Pediatr 1980;97:337-45.
54. Paradise JL, Bluestone CD, Bachman RZ, et al. Efficacy of tonsillectomy for recurrent throat infection in severely affected children: results of parallel randomized and nonrandomized clinical trials. N Engl J Med 1984:310:674-83.
55. Tanz RR, Poncher JR, Corydon KE, Kabat K, Yogev R. Shulman ST. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr 1991; 119:123-8.
56. Orrling A, Stjeraquist-Desatnik A, Schalen C, Kamme C. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Scand J Infect Dis 1994;26:535-41.
57. Kaplan EL, Johnson DR. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr 1988; 113:400-3.
58. Tanz RR, Shulman ST. Barthel MJ, Willert C, Yogev R. Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr 1985; 106:876-80.